Creating Production Standards in the CBD Industry

 

You may have noticed the surge of CBD products on shelves near you. Whether it’s at your local pharmacy, drug store, or even coffee shop, CBD is popping up everywhere in lotions, lattes, gummies, and oils. But how healthy is it, and what sort of quality and production standards are being set?

Here to answer our burning questions about this burgeoning industry on today’s Food & Beverage podcast is Kate Kinnison, vice president of sales and owner of RAD Extracts, a Colorado based B2B CBD supplier.

CBD (short for cannabidiol), is most commonly derived from the hemp plant. Hemp has gotten a bad rap because of its cousin, the marijuana plant, known to contain the psychoactive compound THC. But marijuana and hemp share another compound—CBD, which is completely legal and has shown positive health benefits in initial studies.

Kinnison explained how there’s more to CBD than just the compound itself. RAD Extracts looks at the hemp plant’s benefits holistically, utilizing all of hemp’s cannabinoids to create a product with the utmost benefit.

It comes down to, “All of those compounds in that plant working together in a synergistic feature, to really have the maximum benefits for individuals who are using it,” Kinnison said.

CBD is still rather unregulated, with no guarantee of the quality, purity, or efficacy of what’s hitting shelves. RAD Extracts aims to be ahead of the game, exercising the highest quality practices in their production to produce full-spectrum CBD, not a less-potent distillate.

“By creating a premium full spectrum product we really feel like we’re doing the plant justice,” Kinnison said.

So who could benefit from CBD?

“The amount of different applications it has is amazing,” Kinnison said, with some patients reporting it helping with conditions as varied as acute pain, chronic pain, epilepsy, anxiety, Alzheimers, and even acne.

The future of CBD is still unsure, but Kinnison projected that hemp’s popularity will increase as studies continue to come out touting the benefits of CBD.

For the latest news, videos, and podcasts in the Food & Beverage Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @FoodMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More